COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
31.57
08-July-25 13:45:00
15 minutes delayed
Stocks
+0.67
+2.17%
Today's range
30.60 - 31.74
ISIN
N/A
Source
NASDAQ
-
Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
13 Jun 2024 05:00:00 By Nasdaq GlobeNewswire
-
Collegium to Participate in Jefferies Global Healthcare Conference
29 May 2024 05:00:01 By Nasdaq GlobeNewswire
-
Collegium Announces $35 Million Accelerated Share Repurchase Program
13 May 2024 05:00:00 By Nasdaq GlobeNewswire
-
Collegium Reports First Quarter 2024 Financial Results
09 May 2024 13:02:00 By Nasdaq GlobeNewswire
-
Collegium Announces CEO Transition
09 May 2024 13:01:00 By Nasdaq GlobeNewswire
-
29 Apr 2024 05:00:00 By Nasdaq GlobeNewswire
-
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
25 Apr 2024 05:00:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 05:00:00 By Nasdaq GlobeNewswire
-
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
03 Apr 2024 05:00:00 By Nasdaq GlobeNewswire
-
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
22 Feb 2024 13:09:56 By Nasdaq GlobeNewswire
-
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
08 Feb 2024 05:00:00 By Nasdaq GlobeNewswire
-
Collegium Provides 2024 Financial Guidance
03 Jan 2024 05:00:00 By Nasdaq GlobeNewswire
-
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
27 Nov 2023 05:00:00 By Nasdaq GlobeNewswire
-
Collegium Announces $25 Million Accelerated Share Repurchase Program
09 Nov 2023 05:00:01 By Nasdaq GlobeNewswire
-
Collegium to Participate in Upcoming Investor Conferences
08 Nov 2023 05:00:00 By Nasdaq GlobeNewswire
-
Collegium Reports Third Quarter 2023 Financial Results
07 Nov 2023 13:01:01 By Nasdaq GlobeNewswire
-
Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
24 Oct 2023 05:00:01 By Nasdaq GlobeNewswire
-
Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
28 Aug 2023 05:00:00 By Nasdaq GlobeNewswire
-
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
24 Aug 2023 05:00:00 By Nasdaq GlobeNewswire
-
Collegium Announces $50 Million Accelerated Share Repurchase Program
07 Aug 2023 04:30:00 By Nasdaq GlobeNewswire